GlaxoSmithKline, Alcon switch 3 meds to OTC in play for big volume

18th February 2020 Uncategorised 0

Drugmakers usually target two things: pricing and volume, hopefully both at the same time. But when prices go down, volume’s the thing, and GSK and Alcon have pulled off prescription-to-OTC switches in hopes of giving aging brands a boost.

More: GlaxoSmithKline, Alcon switch 3 meds to OTC in play for big volume
Source: fierce